AASM (2005) International classification of sleep disorders. Diagnostic and coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester
Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, Aldrich MS (2000) Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 55(9):1410-1412
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4(2):101-119
Altena E, Van Der Werf YD, Sanz-Arigita EJ, Voorn TA, Rombouts SA, Kuijer JP, Van Someren EJ (2008) Prefrontal hypoactivation and recovery in insomnia. Sleep 31(9):1271-1276
Andersson JL, Onoe H, Hetta J, Lidstrom K, Valind S, Lilja A, Langstrom B (1998) Brain networks affected by synchronized sleep visualized by positron emission tomography. J Cereb Blood Flow Metab 18(7):701-715
Bar KJ, Hager F, Nenadic I, Opfermann T, Brodhun M, Tauber RF, Sauer H (2002) Serial positron emission tomographic findings in an atypical presentation of fatal familial insomnia. Arch Neurol 59(11):1815-1818
Barriere G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I (2005) The restless legs syndrome. [Review]. Prog Neurobiol 77(3):139-165. doi: 10.1016/j.pneurobio.2005.10.007
Bassetti C, Vella S, Donati F, Wielepp P, Weder B (2000) SPECT during sleepwalking. Lancet 356(9228):484-485
Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, Herscovitch P (1997) Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 120(Pt 7):1173-1197
Braun AR, Balkin TJ, Wesensten NJ, Gwadry F, Carson RE, Varga M, Herscovitch P (1998) Dissociated pattern of activity in visual cortices and their projections during human rapid eye movement sleep. Science 279(5347):91-95
Buysse DJ, Tu XM, Cherry CR, Begley AE, Kowalski J, Kupfer DJ, Frank E (1999) Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry 45(2):205-213
Caselli RJ, Chen K, Bandy D, Smilovici O, Boeve BF, Osborne D, Reiman EM (2006) A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. [Research Support, N.I.H., Extramural Research Support, Non- - U.S. Gov't]. Sleep 29(7):927-933
Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, Farde L (2006) Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. [Research Support, Non-U.S. Gov't]. Brain 129(Pt 8):2017-2028. doi: 10.1093/brain/awl163
Chabas D, Habert MO, Maksud P, Tourbah A, Minz M, Willer JC, Arnulf I (2007) Functional imaging of cataplexy during status cataplecticus. Sleep 30(2):153-156
Cortelli P, Perani D, Parchi P, Grassi F, Montagna P, De Martin M, Fazio F (1997) Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease- resistant prion protein. Neurology 49(1):126-133
Cortelli P, Perani D, Montagna P, Gallassi R, Tinuper P, Provini F, Gambetti P (2006) Pre- symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDGPET studies. Brain 129(Pt 3):668-675
Culebras A, Moore JT (1989) Magnetic resonance findings in REM sleep behavior disorder. Neurology 39(11):1519-1523
Dang-Vu TT, Desseilles M, Petit D, Mazza S, Montplaisir J, Maquet P (2007) Neuroimaging in sleep medicine. Sleep Med 8(4):349-372
Dang-Vu TT, Desseilles M, Schwartz S, Maquet P (2009) Neuroimaging of narcolepsy. CNS Neurol Disord Drug Targets 8(4):254-263
Dang-Vu TT, Gagnon JF, Vendette M, Soucy JP, Postuma RB, Montplaisir J (2012) Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder. Neurology 79(24):2302-2306. doi: 10.1212/WNL.0b013e318278b658
Dauvilliers Y, Arnulf I, Mignot E (2007) Narcolepsy with cataplexy. [Review]. Lancet 369(9560):499-511. doi: 10.1016/S0140-6736(07)60237-2
Dauvilliers Y, Comte F, Bayard S, Carlander B, Zanca M, Touchon J (2010) A brain PET study in patients with narcolepsy-cataplexy. J Neurol Neurosurg Psychiatry 81(3):344-348. doi: 10.1136/jnnp.2009.175786
Dauvilliers Y, Boudousq V, Lopez R, Gabelle A, Cochen De Cock V, Bayard S, Peigneux P (2011) Increased perfusion in supplementary motor area during a REM sleep behaviour episode. Sleep Med 12(5):531-532
Dempsey OJ, McGeoch P, de Silva RN, Douglas NJ (2003) Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation. Neurology 61(4):537-540
Derry C, Benjamin C, Bladin P, le Bars D, Tochon-Danguy H, Berkovic SF, Reutens D (2006) Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy. Neuroimage 30(2):341-348. doi: 10.1016/j.neuroimage.2005.09.052
Desseilles M, Dang-Vu T, Schabus M, Sterpenich V, Maquet P, Schwartz S (2008) Neuroimaging insights into the pathophysiology of sleep disorders. Sleep 31(6):777-794
Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386(6627):824-827. doi: 10.1038/386824a0
Drummond SP, Gillin JC, Brown GG (2001) Increased cerebral response during a divided attention task following sleep deprivation. J Sleep Res 10(2):85-92
Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas R, Brasic J, Allen RP (2011) The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. [Research Support, N.I.H., Extramural]. Sleep 34(3):341-347
Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas RE, Brasic JR, Allen RP (2013) Increased synaptic dopamine in the putamen in restless legs syndrome. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Sleep 36(1):51-57. doi: 10.5665/sleep.2300
Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K (2000) Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 123(Pt 6):1155-1160
Eisensehr I, Wetter TC, Linke R, Noachtar S, von Lindeiner H, Gildehaus FJ, Tatsch K (2001) Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 57(7):1307-1309
Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, Noachtar S (2003a) Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 26(5):507-512
Eisensehr I, Linke R, Tatsch K, von Lindeiner H, Kharraz B, Gildehaus FJ, Noachtar S (2003b) Alteration of the striatal dopaminergic system in human narcolepsy. Neurology 60(11):1817-1819
Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Sato K (2010) Diffuse occipital hypometabolism on [18F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies? [Research Support, Non-U.S. Gov't]. Psychogeriatrics 10(3):144-152. doi: 10.1111/j.1479-8301.2010.00325.x
Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, Montplaisir J (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. [Research Support, Non-U.S. Gov't]. Ann Neurol 66(1):39-47. doi: 10.1002/ana.21680
Germain A, Nofzinger EA, Kupfer DJ, Buysse DJ (2004) Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry 161(10):1856-1863
Gilman S, Koeppe RA, Chervin RD, Consens FB, Little R, An H, Heumann M (2003) REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. [Clinical Trial Controlled Clinical Trial Research Support, U.S. Gov't, P.H.S.]. Neurology 61(1):29-34
Gomez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A (2007) Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 13(6):805-808
Hanyu H, Inoue Y, Sakurai H, Kanetaka H, Nakamura M, Miyamoto T, Iwamoto T (2011) Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder. Eur J Neurol 18(5):784-788
Happe S, Pirker W, Klosch G, Sauter C, Zeitlhofer J (2003) Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. [Research Support, Non-U.S. Gov't]. J Neurol 250(1):83-86. doi: 10.1007/s00415-003-0957-8
Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE Jr (1996) Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. Arch Gen Psychiatry 53(7):645-652
Hong SB, Tae WS, Joo EY (2006) Cerebral perfusion changes during cataplexy in narcolepsy patients. Neurology 66(11):1747-1749
Hublin C, Launes J, Nikkinen P, Partinen M (1994) Dopamine D2-receptors in human narcolepsy: a SPECT study with 123I-IBZM. Acta Neurol Scand 90(3):186-189
Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N (1999) SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. [Clinical Trial]. J Nucl Med 40(10):1583-1589
Iranzo A, Lomena F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Santamaria J (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. [Comparative Study]. Lancet Neurol 9(11):1070-1077. doi: 10.1016/S1474-4422(10)70216-7
Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapideye- movement sleep behaviour disorder: a prospective study. Lancet Neurol 10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1
Jones BE (1991) Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 40(3):637-656
Joo EY, Tae WS, Kim JH, Kim BT, Hong SB (2004) Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 56(3):437-440
Joo EY, Tae WS, Jung KY, Hong SB (2008) Cerebral blood flow changes in man by wakepromoting drug, modafinil: a randomized double blind study. J Sleep Res 17(1):82-88
Kajimura N, Uchiyama M, Takayama Y, Uchida S, Uema T, Kato M, Takahashi K (1999) Activity of midbrain reticular formation and neocortex during the progression of human non-rapid eye movement sleep. J Neurosci 19(22):10065-10073
Khan N, Antonini A, Parkes D, Dahlitz MJ, Meier-Ewert K, Weindl A, Leenders KL (1994) Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride. Neurology 44(11):2102-2104
Kim YK, Yoon IY, Shin YK, Cho SS, Kim SE (2007) Modafinil-induced hippocampal activation in narcolepsy. Neurosci Lett 422(2):91-96
Kim YK, Yoon IY, Kim JM, Jeong SH, Kim KW, Shin YK, Kim SE (2010) The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol 17(3):487-492
Kim KW, Jhoo JH, Lee SB, Lee SD, Kim TH, Kim SE, Yoon IY (2012) Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients. [Research Support, Non-U.S. Gov't]. Eur J Neurol 19(9):1213-1218. doi: 10.1111/j.1468-1331.2012.03705.x
Kimura K, Tachibana N, Kohyama J, Otsuka Y, Fukazawa S, Waki R (2000) A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology 55(6):894-895
Kloppel S, Pirker W, Brucke T, Kovacs GG, Almer G (2002) Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia. J Neural Transm 109(7-8):1105-1110
Limousin N, Dehais C, Gout O, Heran F, Oudiette D, Arnulf I (2009) A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med 10(9):1059-1062
Linke R, Eisensehr I, Wetter TC, Gildehaus FJ, Popperl G, Trenkwalder C, Tatsch K (2004) Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease? Mov Disord 19(10):1158-1162
Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Gambetti P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315(16):997-1003
MacFarlane JG, List SJ, Moldofsky H, Firnau G, Chen JJ, Szechtman H, Nahmias C (1997) Dopamine D2 receptors quantified in vivo in human narcolepsy. Biol Psychiatry 41(3):305-310
Maquet P (2000) Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Res 9(3):207-231
Maquet P, Franck G (1997) REM sleep and amygdala. Mol Psychiatry 2(3):195-196
Maquet P, Dive D, Salmon E, Sadzot B, Franco G, Poirrier R, Franck G (1990) Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose method. Brain Res 513(1):136-143
Maquet P, Peters J, Aerts J, Delfiore G, Degueldre C, Luxen A, Franck G (1996) Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 383(6596):163-166
Maquet P, Laureys S, Peigneux P, Fuchs S, Petiau C, Phillips C, Cleeremans A (2000) Experiencedependent changes in cerebral activation during human REM sleep. Nat Neurosci 3(8):831-836
Maquet P, Ruby P, Maudoux A, Albouy G, Sterpenich V, Dang-Vu T, Laureys S (2005) Human cognition during REM sleep and the activity profile within frontal and parietal cortices: a reappraisal of functional neuroimaging data. Prog Brain Res 150:219-227
Mazza S, Soucy JP, Gravel P, Michaud M, Postuma R, Massicotte-Marquez J, Montplaisir J (2006) Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology 67(9):1618-1622
Meyer JS, Sakai F, Karacan I, Derman S, Yamamoto M (1980) Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Ann Neurol 7(5):479-485
Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J (2002) SPECT imaging of striatal preand postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 249(2):164-170
Miyamoto T, Orimo S, Miyamoto M, Hirata K, Adachi T, Hattori R, Ishii K (2010) Follow-up PET studies in case of idiopathic REM sleep behavior disorder. [Case Reports]. Sleep Med 11(1):100-101. doi: 10.1016/j.sleep.2009.05.006
Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2(3):167-176
Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P (1997) Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12(1):61-65
Mrowka M, Jobges M, Berding G, Schimke N, Shing M, Odin P (2005) Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm 112(5):693-701. doi: 10.1007/s00702-004-0217-9
Muller HL (2010) Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010:519607. doi: 10.1155/2010/519607
Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY (1997) Forebrain activation in REM sleep: an FDG PET study. Brain Res 770(1-2):192-201
Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, Moore RY (1999) Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies. Psychiatry Res 91(2):59-78
Nofzinger EA, Price JC, Meltzer CC, Buysse DJ, Villemagne VL, Miewald JM, Kupfer DJ (2000) Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res 98(2):71-91
Nofzinger EA, Buysse DJ, Germain A, Carter C, Luna B, Price JC, Kupfer DJ (2004a) Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression. [Comparative Study Research Support, U.S. Gov't, P.H.S.]. Arch Gen Psychiatry 61(7):695-702. doi: 10.1001/archpsyc.61.7.695
Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ (2004b) Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161(11):2126-2128
Ohayon MM, Hong SC (2002) Prevalence of insomnia and associated factors in South Korea. J Psychosom Res 53(1):593-600
Ohayon MM, Roth T (2002) Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53(1):547-554
Pedroso JL, Braga-Neto P, Felicio AC, Minett T, Yamaguchi E, Prado LB, Barsottini OG (2013) Sleep disorders in Machado-Joseph disease: a dopamine transporter imaging study. J Neurol Sci 324(1-2):90-93. doi: 10.1016/j.jns.2012.10.008
Peigneux P, Laureys S, Fuchs S, Delbeuck X, Degueldre C, Aerts J, Maquet P (2001) Generation of rapid eye movements during paradoxical sleep in humans. Neuroimage 14(3):701-708
Pennestri MH, Whittom S, Adam B, Petit D, Carrier J, Montplaisir J (2006) PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution. Sleep 29(9):1183-1187
Perani D, Cortelli P, Lucignani G, Montagna P, Tinuper P, Gallassi R, Fazio F (1993) [18F] FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 43(12):2565-2569
Perlis ML, Merica H, Smith MT, Giles DE (2001) Beta EEG activity and insomnia. Sleep Med Rev 5(5):363-374
Picchietti D (2006) Periodic limb movements in sleep: irrelevant epiphenomenon, marker for a potential problem, or a disorder? J Clin Sleep Med 2(4):446-447
Plazzi G, Montagna P (2002) Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 3(5):437-439
Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. [Research Support, Non-U.S. Gov't]. Neurology 72(15):1296-1300. doi: 10.1212/01. wnl.0000340980.19702.6e
Provini F, Vetrugno R, Pastorelli F, Lombardi C, Plazzi G, Marliani AF, Montagna P (2004) Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: a state-dependent disorder of motor control during sleep. Mov Disord 19(6):719-723
Rinne JO, Hublin C, Partinen M, Ruottinen H, Ruotsalainen U, Nagren K, Laihinen A (1995) Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors. Neurology 45(9):1735-1738
Rinne JO, Hublin C, Nagren K, Helenius H, Partinen M (2004) Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT. Acta Neurol Scand 109(1):52-55
Ruottinen HM, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O, Rinne JO (2000) An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 54(2):502-504
Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25(2):120-138
Shirakawa S, Takeuchi N, Uchimura N, Ohyama T, Maeda H, Abe T, Ohshima H (2002) Study of image findings in rapid eye movement sleep behavioural disorder. Psychiatry Clin Neurosci 56(3):291-292
Smith MT, Perlis ML, Chengazi VU, Pennington J, Soeffing J, Ryan JM, Giles DE (2002) Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study. Sleep 25(3):325-335
Smith MT, Perlis ML, Chengazi VU, Soeffing J, McCann U (2005) NREM sleep cerebral blood flow before and after behavior therapy for chronic primary insomnia: preliminary single photon emission computed tomography (SPECT) data. Sleep Med 6(1):93-94
Staedt J, Stoppe G, Kogler A, Munz D, Riemann H, Emrich D, Ruther E (1993) Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm Gen Sect 93(1):71-74
Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Munz DL, Ruther E (1995a) Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. [Comparative Study]. Eur Arch Psychiatry Clin Neurosci 245(1):8-10
Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Munz DL, Ruther E (1995b) Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). [Clinical Trial]. J Neural Transm Gen Sect 99(1-3):187-193
Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Rodenbeck A, Ruther E (1996) [123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment. Biol Psychiatry 39(2):107-111. doi: 10.1016/0006-3223(95)00087-9
Stanwood GD, Lucki I, McGonigle P (2000) Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. J Pharmacol Exp Ther 295(3):1232-1240
Steriade M, McCarley RW (1990) Brainstem control of wakefulness and sleep. Plenum Press, New York
Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CITSPECT. Brain 128(Pt 1):126-137
Sudo Y, Suhara T, Honda Y, Nakajima T, Okubo Y, Suzuki K, Matsushita M (1998) Muscarinic cholinergic receptors in human narcolepsy: a PET study. Neurology 51(5):1297-1302
Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, Kung HF (1997) Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med 24(4):415-421
Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R, Redmond D (2000) Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res 9(4):335-352
Tippmann-Peikert M, Boeve BF, Keegan BM (2006) REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 66(8):1277-1279
Trenkwalder C, Paulus W (2010) Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 6(6):337-346. doi: 10.1038/nrneurol.2010.55
Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Antonini A, Dhawan V, Eidelberg D (1999) Positron emission tomographic studies in restless legs syndrome. [Research Support, Non-U.S. Gov't]. Mov Disord 14(1):141-145
Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Sampaio C (2008) Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. [Research Support, Non-U.S. Gov't Review]. Mov Disord 23(16):2267-2302. doi: 10.1002/mds.22254
Tribl GG, Asenbaum S, Klosch G, Mayer K, Bonelli RM, Auff E, Happe S (2002) Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 59(4):649-650
Tribl GG, Asenbaum S, Happe S, Bonelli RM, Zeitlhofer J, Auff E (2004) Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep. Nucl Med Commun 25(1):55-60
Tsuno N, Besset A, Ritchie K (2005) Sleep and depression. J Clin Psychiatry 66(10):1254-1269
Turjanski N, Lees AJ, Brooks DJ (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52(5):932-937
Unger MM, Moller JC, Stiasny-Kolster K, Mankel K, Berg D, Walter U, Oertel WH (2008) Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT. [Research Support, Non-U.S. Gov't]. Mov Disord 23(4):596-599. doi: 10.1002/mds.21908
Vendette M, Gagnon JF, Soucy JP, Gosselin N, Postuma RB, Tuineag M, Montplaisir J (2011) Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord 26(9):1717-1724. doi: 10.1002/mds.23721
von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, Brooks DJ (2005) The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. [Research Support, Non-U.S. Gov't]. Brain 128(Pt 4):906-917. doi: 10.1093/brain/awh441
Walters AS (2002) Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med 3(4):301-304
Wehrle R, Czisch M, Kaufmann C, Wetter TC, Holsboer F, Auer DP, Pollmacher T (2005) Rapid eye movement-related brain activation in human sleep: a functional magnetic resonance imaging study. Neuroreport 16(8):853-857
Xi Z, Luning W (2009) REM sleep behavior disorder in a patient with pontine stroke. Sleep Med 10(1):143-146
Yeon Joo E, Hong SB, Tae WS, Kim JH, Han SJ, Cho YW, Kim L (2005) Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 28(2):410-416
Zambelis T, Paparrigopoulos T, Soldatos CR (2002) REM sleep behaviour disorder associated with a neurinoma of the left pontocerebellar angle. J Neurol Neurosurg Psychiatry 72(6):821-822
